DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

57.16 -0.39 (-0.68%)

REAL-TIME: Last trade at

Extended Hours: $57.25 $0.09 (0.16%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

ISIS $57.16 -0.68%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $58.51
Previous Close $57.55
Daily Range $56.50 - $58.73
52-Week Range $27.37 - $77.80
Market Cap $6.8B
P/E Ratio -287.75
Dividend (Yield) $0.00 (0.0%)
Volume 2,128,186
Average Daily Volume 2,548,875
Current FY EPS -$0.26




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Strong Upward Pre-Market Activity For ISIS Pharmaceuticals (ISIS)

Should Isis Pharmaceuticals (ISIS) Be On Your Radar Now? - Tale of the Tape

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Commit To Purchase Isis Pharmaceuticals At $33, Earn 9.1% Using Options

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

ISIS Pharma Still Undervalued, Needham Says

IWM, CRBN: Big ETF Inflows

Health Care Sector Update for 06/22/2015: PFE, ISIS, KPTI

Amgen, Regeneron LDL-Lowering Drugs Provide Major Upside Potential To Their Stocks

See More ISIS News...

ISIS's Top Competitors

ISIS $57.16 (-0.68%)
Current stock: ISIS
AMGN $154.99 (0.96%)
Current stock: AMGN
GILD $116.01 (-0.91%)
Current stock: GILD
BIIB $405.41 (0.36%)
Current stock: BIIB